Allen R. Nissenson
#149,088
Most Influential Person Now
Allen R. Nissenson's AcademicInfluence.com Rankings
Allen R. Nissensonphilosophy Degrees
Philosophy
#8167
World Rank
#11495
Historical Rank
Logic
#5197
World Rank
#6576
Historical Rank
Download Badge
Philosophy
Why Is Allen R. Nissenson Influential?
(Suggest an Edit or Addition)Allen R. Nissenson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- K/DOQI clinical practice guidelines for chronic kidney disease (2002) (8858)
- K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. (2003) (2521)
- The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. (1998) (1298)
- K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease (2004) (1050)
- IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. (2001) (464)
- Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. (2003) (458)
- Pure red-cell aplasia and epoetin therapy. (2004) (423)
- Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. (2010) (420)
- NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative. (1997) (387)
- Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. (2009) (324)
- The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. (2010) (317)
- Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. (2005) (301)
- Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. (2003) (294)
- Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. (2010) (269)
- Normalizing hematocrit in dialysis patients improves brain function. (1999) (254)
- rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. (1991) (245)
- Anemia: not just an innocent bystander? (2003) (237)
- Race, gender, and socioeconomic disparities in CKD in the United States. (2008) (228)
- The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. (1996) (227)
- Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. (2002) (213)
- Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. (2002) (198)
- Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature. (2004) (192)
- Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. (2001) (185)
- Chronic Kidney Disease in the United States (2008) (184)
- Non-medical factors that impact on ESRD modality selection. (1993) (176)
- Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. (1993) (175)
- Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. (2011) (168)
- Dietary potassium intake and mortality in long-term hemodialysis patients. (2010) (163)
- Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. (2013) (154)
- Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. (2010) (154)
- Associations of Body Mass Index and Weight Loss with Mortality in Transplant‐Waitlisted Maintenance Hemodialysis Patients (2011) (151)
- Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. (2007) (146)
- Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. (2008) (138)
- Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. (2009) (134)
- Improving clinical outcomes among hemodialysis patients: a proposal for a "volume first" approach from the chief medical officers of US dialysis providers. (2014) (131)
- Systemic lupus erythematosus in pregnancy. (1981) (131)
- Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). (2008) (129)
- Quality of life in chronic dialysis patients: a critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. (1988) (127)
- Association of hemodialysis treatment time and dose with mortality and the role of race and sex. (2010) (119)
- Acute renal failure: definition and pathogenesis. (1998) (118)
- Treatment compliance in end-stage renal disease patients on dialysis. (1986) (118)
- Patterns and Predictors of Early Mortality in Incident Hemodialysis Patients: New Insights (2012) (112)
- Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS). (2017) (111)
- Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial. (1999) (109)
- Epoetin and cognitive function. (1992) (105)
- Economic burden of anemia in an insured population. (2004) (104)
- Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. (1989) (104)
- Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. (2012) (102)
- Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes (2012) (101)
- Impact of Race on Hyperparathyroidism, Mineral Disarrays, Administered Vitamin D Mimetic, and Survival in Hemodialysis Patients (2010) (100)
- The association of poverty with the prevalence of albuminuria: data from the Third National Health and Nutrition Examination Survey (NHANES III). (2006) (100)
- Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. (2003) (99)
- Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. (2005) (98)
- Multicenter clinical validation of an on-line monitor of dialysis adequacy. (1996) (96)
- Relationship of dialysis modality and other factors to cognitive function in chronic dialysis patients. (1988) (94)
- Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients (2012) (91)
- Quality of life in chronic dialysis patients. Factors unrelated to dialysis modality. (1988) (89)
- Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. (2011) (89)
- Improving outcomes for ESRD patients: shifting the quality paradigm. (2014) (89)
- Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. (2001) (87)
- Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. (2013) (85)
- Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects. (1991) (85)
- National Cooperative rHu Erythropoietin Study in patients with chronic renal failure--an interim report. The National Cooperative rHu Erythropoietin Study Group. (1993) (84)
- Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients. (2011) (84)
- The normal hematocrit study--follow-up. (2008) (80)
- Association of Cumulatively Low or High Serum Calcium Levels with Mortality in Long-Term Hemodialysis Patients (2010) (79)
- ESRD modality selection into the 21st century: the importance of non medical factors. (1997) (77)
- Effect of age and dialysis vintage on obesity paradox in long-term hemodialysis patients. (2014) (77)
- Associations of Pretransplant Serum Albumin with Post‐Transplant Outcomes in Kidney Transplant Recipients (2011) (75)
- Iron deficiency in patients with renal failure. (1999) (75)
- Erythropoietin and anemia. (2001) (74)
- Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. (2013) (72)
- Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. (2012) (71)
- Recombinant human erythropoietin: impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. (1989) (68)
- Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis. (2015) (68)
- Racial and Ethnic Differences in Mortality of Hemodialysis Patients: Role of Dietary and Nutritional Status and Inflammation (2011) (68)
- Hypoxemia and pulmonary gas exchange during hemodialysis. (1981) (67)
- Poststreptococcal acute glomerulonephritis: fact and controversy. (1979) (67)
- Impact of Age, Race and Ethnicity on Dialysis Patient Survival and Kidney Transplantation Disparities (2014) (65)
- Morbidity and mortality of continuous ambulatory peritoneal dialysis: regional experience and long-term prospects. (1986) (65)
- Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States. (2016) (64)
- Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. (2011) (63)
- Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. (2005) (63)
- Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients. (2003) (63)
- Cognitive function, mood and P3 latency: Effects of the amelioration of anemia in dialysis patients (1991) (61)
- Electrophysiological indices of CNS function in hemodialysis and CAPD. (1986) (61)
- Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients. (2010) (61)
- Mortality predictability of body size and muscle mass surrogates in Asian vs white and African American hemodialysis patients. (2013) (61)
- Ownership patterns of dialysis units and peritoneal dialysis in the United States: utilization and outcomes. (2009) (60)
- Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia? (2009) (57)
- Serum Ferritin in Chronic Kidney Disease: Reconsidering the Upper Limit for Iron Treatment (2004) (57)
- Complications of peritoneal dialysis: evaluation with CT peritoneography. (1997) (57)
- Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. (1990) (56)
- Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease. (2001) (56)
- Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients (2010) (54)
- Multicenter trial of erythropoietin in patients on peritoneal dialysis. (1995) (53)
- Predictors of treatment with dialysis modalities in observational studies for comparative effectiveness research. (2015) (52)
- Medicare's end-stage renal disease program: current status and future prospects. (1999) (52)
- The Human Nephron Filter: Toward a Continuously Functioning, Implantable Artificial Nephron System (2005) (51)
- Nutritional predictors of early mortality in incident hemodialysis patients (2013) (51)
- The chronic kidney disease initiative. (2004) (51)
- Anemia and its clinical consequences in patients with chronic diseases. (2004) (50)
- Disease management in chronic kidney disease. (2008) (49)
- International dialysis aid in earthquakes and other disasters. (1993) (49)
- Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. (2013) (49)
- High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients. (2011) (49)
- The relationship between laboratory‐based outcome measures and mortality in end‐stage renal disease: A systematic review (2009) (49)
- Hemodiabsorption in treatment of hepatic failure. (1998) (48)
- PD First: Peritoneal Dialysis as the Default Transition to Dialysis Therapy (2013) (47)
- Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease (2010) (46)
- Selection of ESRD treatment: an international study. (1989) (45)
- Chronic kidney disease in the United States: a public policy imperative. (2008) (45)
- Mortality differences among organisms causing septicemia in hemodialysis patients (2006) (44)
- The new FDA label for erythropoietin treatment: how does it affect hemoglobin target? (2007) (43)
- Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. (1989) (43)
- Handbook of Dialysis Therapy (2008) (42)
- Metabolic Profiling of Impaired Cognitive Function in Patients Receiving Dialysis. (2016) (41)
- Evaluation of disease-state management of dialysis patients. (2001) (41)
- Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients (2013) (40)
- Identifying best practices in dialysis care: results of cognitive interviews and a national survey of dialysis providers. (2008) (40)
- Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how do we find it out? (1993) (38)
- High Prevalence of Stage 3 Chronic Kidney Disease in Older Adults Despite Normal Serum Creatinine (2008) (38)
- Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic Kidney Transplant Recipients (2011) (38)
- National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group. (1991) (37)
- Costs of managing anemia with erythropoiesis‐stimulating agents during hemodialysis: A time and motion study (2008) (37)
- Dialysis therapy in the elderly patient. (1993) (36)
- Hemodialysis in the treatment of psoriasis. A controlled trial. (1979) (35)
- Continued absence of clinical renal disease seven to 12 years after poststreptococcal acute glomerulonephritis in Trinidad. (1979) (35)
- The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration. (2019) (34)
- Does Nanotechnology Apply to Dialysis? (2001) (34)
- Dialysis at a crossroads: 50 years later. (2011) (33)
- Adverse ocular effects of acetate hemodialysis. (1983) (33)
- Controversies in iron management. (2003) (32)
- Peritoneal dialysis in the geriatric patient. (1990) (32)
- Anemia management in chronic kidney disease. (2010) (32)
- Measuring, managing, and improving quality in the end-stage renal disease treatment setting: peritoneal dialysis. (1994) (32)
- Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. (2012) (32)
- Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States. (2015) (31)
- HYPERTENSION IN HEMODIALYSIS PATIENTS: Role of Sodium and Volume in the Pathogenesis of Hypertension in Hemodialysis (2004) (31)
- Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey. (2009) (31)
- The case for disease management in chronic kidney disease. (2006) (30)
- Achieving target hematocrit in dialysis patients: new concepts in iron management. (1997) (29)
- Accountable care organizations and ESRD: the time has come. (2012) (29)
- Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis. (2016) (29)
- Effects of Oral Nutritional Supplements on Mortality, Missed Dialysis Treatments, and Nutritional Markers in Hemodialysis Patients. (2017) (28)
- Clearance of aluminum by hemodialysis: effect of desferrioxamine. (1986) (28)
- Complications of chronic renal insufficiency: beyond cardiovascular disease. (2000) (28)
- Outcome of end-stage renal disease in patients with rare causes of renal failure. II. Renal or systemic neoplasms. (1989) (27)
- Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations (2006) (27)
- Dialysis practices that distinguish facilities with below- versus above-expected mortality. (2010) (27)
- The IMPACT (Incident Management of Patients, Actions Centered on Treatment) program: a quality improvement approach for caring for patients initiating long-term hemodialysis. (2012) (23)
- Association of pretransplant serum phosphorus with posttransplant outcomes. (2011) (23)
- Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis. (1987) (23)
- Dose of Hemodialysis and Survival: A Marginal Structural Model Analysis (2014) (22)
- Optimal hematocrit in patients on dialysis therapy. (1998) (22)
- Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients. (2011) (22)
- Racial disparities in chronic kidney disease: tragedy, opportunity, or both? (2008) (21)
- A randomized double‐blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology (2009) (21)
- Technological advances in renal replacement therapy: five years and beyond. (2009) (21)
- Dialysis-associated hypoxemia: pathogenesis and prevention (1984) (20)
- Target haematocrit during erythropoietin therapy. (1997) (20)
- Title Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes : A 6-year cohort study (2012) (20)
- Racial differences in mortality and ESRD. (2008) (20)
- Toward population management in an integrated care model. (2013) (19)
- Erythropoietin overview--1993. (1994) (19)
- Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. (2013) (19)
- Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia (2011) (18)
- Chronic peritoneal dialysis in the elderly (1991) (18)
- Special Article: Improving Outcomes in CKD and ESRD Patients: Carrying the Torch from Training to Practice (2004) (18)
- Dialysis at a crossroads--Part II: A call for action. (2012) (17)
- Dialyzer reuse with peracetic acid does not impact patient mortality. (2011) (17)
- Ownership of dialysis facilities and patients' survival [4] (multiple letters) (2000) (16)
- The role of renal biopsy in determining therapy and prognosis in renal disease. (1982) (16)
- Vascular Access for HD: Aligning Payment with Quality (2011) (16)
- Guiding principles and checklist for population-based quality metrics. (2014) (16)
- Neurological sequelae of end stage renal disease (ESRD). (1977) (16)
- Catheter use is high even among hemodialysis patients with a fistula or graft. (2006) (15)
- A quality initiative. Reducing rates of hospitalizations by objectively monitoring volume removal. (2013) (15)
- Carbon transcutaneous access device (CTAD). (1980) (15)
- Vascular access for hemodialysis (2006) (15)
- Hyporesponsiveness to Erythropoietin: Overview, 1996 (1996) (14)
- Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin. (2006) (14)
- Automated Peritoneal Dialysis Symposium: Determinants in APD Selection (2002) (14)
- Effect of renal failure and hemodialysis on cephacetrile pharmacoki netics (1972) (14)
- Prevention of dialysis-induced hypoxemia by bicarbonate dialysis. (1980) (14)
- Relationship among length of facility ownership, clinical performance, and mortality. (2010) (14)
- Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee. (1997) (13)
- The Normal Haematocrit Trial in dialysis patients with cardiac disease. (1999) (13)
- Case-mix and treatment in end-stage renal disease: hemodialysis v peritoneal dialysis. (1988) (13)
- Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation (2014) (13)
- Hemodiabsorption in Treatment of Hepatic Failure (1998) (12)
- L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they? (2003) (12)
- Association of pre-transplant erythropoiesis-stimulating agent responsiveness with post-transplant outcomes. (2012) (12)
- Dialysis practices that distinguish top- versus bottom-performing facilities by hemoglobin outcomes. (2010) (12)
- Utilizing a Disease Management Approach to Improve ESRD Patient Outcomes (2002) (12)
- The future of renal replacement therapy. (2007) (12)
- Restructuring the ESRD payment system in the United States. (2004) (12)
- The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization. (2010) (11)
- Innovation in the Treatment of Uremia: Proceedings from the Cleveland Clinic Workshop: Bottom‐Up Nanotechnology: The Human Nephron Filter (2009) (11)
- ESRD special needs plans: a proof of concept for integrated care. (2014) (11)
- Socioeconomic Status of Counties Where Dialysis Clinics Are Located Is an Important Factor in Comparing Dialysis Providers. (2016) (11)
- Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study. (1990) (11)
- The evolving role of the medical director of a dialysis facility. (2015) (11)
- Postpartum hemolytic uremic syndrome. Late recovery after prolonged maintenance dialysis. (1979) (11)
- Moxalactam kinetics in hemodiaiysis (1981) (10)
- Paper Chromatography prior to Cortisol RIA Allows for Accurate Use of the Dexamethasone Suppression Test in Chronic Renal Failure (1998) (10)
- End-stage renal disease and the practice of nephrology. (1989) (10)
- Daily hemodialysis: challenges and opportunities in the delivery and financing of end-stage renal disease patient care. (2001) (10)
- Dialysis in nursing homes. (2002) (9)
- Palliative dialysis: Addressing the need for alternative dialysis delivery modes (2019) (9)
- Quality of Life in Elderly and Diabetic Patients on Peritoneal Dial Ysis (1996) (9)
- Erythropoietin and Peritoneal Dialysis: The Efficacy of Intraperitoneal Dosing (1992) (9)
- Improving outcomes of dialysis patients by population health management—the Global Chief Medical Officer Initiative (2016) (9)
- The ESRD Demonstration Project: what it accomplished. DaVita Inc. (2011) (9)
- Health-Care Economics and Peritoneal Dialysis (1996) (8)
- No-needle dialysis (NND): experience with the new carbon transcutaneous hemodialysis (HD) access device (CTAD). (1981) (8)
- New approaches to the management of anemia of chronic kidney disease: Beyond Epogen and Infed (2006) (7)
- Disease management improves outcomes in patients with CKD. (2003) (6)
- Evaluation of Central Nervous System Function in Dialysis Patients. a Practical Approach with Implications for Selection and Modification of Treatment Modalities (1990) (6)
- CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end‐stage renal disease (2013) (6)
- Morbidity and Mortality of United States Dialysis Patients—–The Legacy of Inadequate Nephrologist Training? (1992) (6)
- Outcomes Associated with a Disease Management Program for End-Stage Renal Disease (2002) (6)
- CAPD in the Elderly—Regional Experience (1986) (6)
- DIALYZING THE ELDERLY: ISSUES AND CONCERNS: Dialysis in Nursing Homes (2002) (6)
- Disease management for ESRD: The time has come (2000) (6)
- Medicare's End-Stage Renal Disease Program (1999) (5)
- Peritoneal Dialysis in the Elderly (1986) (5)
- Models of capitated payment for endstage renal disease. (2001) (5)
- Propranolol and Hypoglycemia in Renal Failure (1978) (5)
- Creating an open dialogue on improving dialysis care. (2013) (5)
- The current and future state of the ESRD program: a provider roundtable. (2000) (5)
- Anemia in Chronic Kidney Disease Patients (2008) (5)
- Peritoneal dialysis in the elderly patient (1994) (5)
- Dialysis for chronic renal failure: comorbidity and treatment differences by disease etiology. (1989) (5)
- Toward Population Management in an Integrated Care Model (2013) (4)
- Managed care--a battlefield for interdisciplinary turf wars or an arena for real improvements in care? (1996) (4)
- Moxalactam kinetics in hemodialysis. (1981) (4)
- Military antishock trousers. Effect on hemodialysis-induced hypotension. (1984) (4)
- The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization. (2011) (4)
- Focused clinical campaign improves mineral and bone disorder outcomes. (2012) (4)
- Hyporesponsiveness to Erythropoietin (1997) (4)
- Stable liquid bicarbonate hemodialysate (LBD). (1984) (4)
- Renal replacement therapy in the elderly. (2009) (4)
- NKF and RPA collaborating on clinical practice guidelines for chronic kidney disease. (2001) (4)
- Assessing the Effects of Peritoneal Dialysis on the Health-Related Quality of Life of the Adult Patient (1997) (4)
- Hispanics with End-Stage Renal Disease (1994) (4)
- Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid (2019) (4)
- Creative strategies for chronic peritoneal dialysis in the elderly (1993) (4)
- Dialysis outcomes as a measure of adequacy of dialysis. (2005) (3)
- A large dialysis provider committed to home modalities. (2012) (3)
- Optimal hematocrit for hemodialysis (1997) (3)
- Long‐term Outcome of Continuous Ambulatory Peritoneal Dialysis: The Southern California/Southern Nevada Experience (1986) (3)
- Controlling health care spending: unintended consequences of a fragmented approach. (1996) (3)
- A 'quiet revolution' in nephrology. (2010) (3)
- Hepatitis C virus infection in patients with end‐stage renal disease (2018) (3)
- Nanotechnology and Dialysis (2004) (3)
- Variations in serum complement following inulin infusion in man. (1979) (3)
- Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies. (2010) (3)
- Reduction of IgG levels in myasthenia. (1977) (3)
- Responses to a phosphate binder given with meals or between meals (1995) (3)
- The future of end-stage renal disease care: nephrology enters a new millennium. (1998) (3)
- Nephrologists and Integrated Kidney Disease Care: Roles and Skills Essential for Nephrologists for Future Success. (2017) (3)
- Should Medical Directors Assume Responsibility for Facility‐Specific Outcomes? (2012) (3)
- 54: Underestimation of Chronic Kidney Disease (CKD) by Measured Serum Creatinine: Data from the National Health and Nutrition Examination Survey (NHANES 1999-2002) (2007) (2)
- Opinion: What Common Practices in Dialysis Units Can Be Altered to Improve Patient Care? (2004) (2)
- Pure Red-Cell Aplasia: An Emerging Epidemic in Dialysis Patients? (2003) (2)
- Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes. (2007) (2)
- Integrated Care in ESKD: Perspective of a Large Dialysis Organization. (2019) (2)
- Medicare Advantage associated with lower mortality for incident dialysis patients. (2015) (2)
- New alternatives in anemia treatment: biosimilars and HIF stabilizers. (2014) (2)
- Peritoneal dialysis case forum. Necrotizing panniculitis in a morbidly obese patient with end-stage renal disease. (1998) (2)
- Anemia in PD Patients (2009) (2)
- How Can the Care of Elderly Dialysis Patients Be Improved? (1992) (2)
- Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson. (2001) (2)
- Accidental salicylate intoxication in a hemodialysis patient. (1988) (2)
- The normal HCT trial re-revisited: what were the actual findings? (2012) (2)
- Chronic Kidney Disease — A Quiet Revolution in Nephrology (2010) (2)
- Quality of Life on In-Center Hemodialysis versus Capd (1992) (2)
- Proceedings From the Symposium on End-Stage Renal Disease Patient Management: Strategies for Meeting the Clinical and Economic Challenges (1993) (1)
- Current diagnosis & treatment (2015) (1)
- Plasticizer effect on heart. (1977) (1)
- Hemodialysis in the Treatment of Psoriasis (2020) (1)
- Chronic Peritoneal Dialysis in the United States: but Declining Utilization Improving Outcomes (2007) (1)
- FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES. (2011) (1)
- Greater access to transplantation should be a priority: A view of the Dialysis PATIENTS Demonstration Act (2018) (1)
- 179: Comparing Mortality-Predictability Of Hyper-Phosphatemia in Maintenance Hemodialysis Patients With And Without Polycystic Kidney Disease (Pkd) (2010) (1)
- Emphasizing patient choice: the modality selection project in ESRD Network 18. (2003) (1)
- Darbepoetin Alfa (2012) (1)
- Nephrology Secrets, 3rd Edition (2011) (1)
- Report of workshop on technique and technology. (1993) (1)
- 84 Comparing Mortality Risk of Minerals, PTH and Alkaline Phosphatase Over 6 Years in 12,422 Chronic Peritoneal Dialysis (CPD) Patients (2011) (1)
- Advancing American Kidney Health: Perspective from DaVita, Inc. (2019) (1)
- Anemia management critical care for the dialysis patient (1996) (1)
- Breaking the Barriers to Innovation in Kidney Care. (2022) (1)
- The ARRT of uremia therapy. (1994) (1)
- Working toward changes in nephrology practice. (2014) (1)
- Organizing a Dialysis Research Program: The UCLA Experience (1998) (1)
- Difficult Management Problems in Dialysis (1993) (1)
- Prioritizing fluid management for the renal community. (2015) (1)
- Subject Index Vol. 19, 2001 (2001) (1)
- Dialysis Modality Selection: Harsh Realities (1996) (1)
- Epoetin dosing and dialysis facility ownership. (2007) (1)
- 191: Secondary Hyperparathyroidism & Survival in Hemo-Dialysis Patients With & Without Polycystic Kidney (2010) (1)
- Sudden Death and Dialysate Potassium in Hemodialysis: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) (2015) (1)
- 58: C.E.R.A. Once Monthly Maintains Stable HB Levels in Patients with CKD on Dialysis with and without Congestive Heart Failure (CHF) (2007) (1)
- Improving Chronic Peritoneal Dialysis (CPD) Outcomes but Unchanged Maintenance Hemodialysis (MHD) Outcomes in the United States (2007) (1)
- 121: Variation in Peritoneal Dialysis (PD) Utilization among Large Dialysis Organizations (LDOs):An Explanation for PD Decrease? (2008) (0)
- Contents Vol. 19, 2001 (2001) (0)
- 16th International Conference on Dialysis. Advances in Chronic Kidney Disease 2014. January 22-25, 2014, Caesars Palace, Las Vegas, Nev.: Abstracts (2013) (0)
- Meeting a complex challenge. Case studies describe successful models of coordinated care for patients with end-stage renal disease. (2000) (0)
- 190:Activity-Based Cost Analysis of In-Center Anemia Treatment in Hemodialysis Patients (2007) (0)
- Extracorporeal mesenchymal stromal cell therapy (SBI-101) in severe COVID-19 complicated by acute kidney injury (2021) (0)
- 212: Improving Medication Access to Reduce Disparities By a Large Dialysis Provider (2010) (0)
- THE BUNDLE IS COMING! THE BUNDLE IS COMING! (2011) (0)
- Acid-base homeostasis in peritoneal dialysis patients. (1984) (0)
- HISPANICS WITH END-STATE RENAL DISEASE. RESPONSE (1994) (0)
- Psychological and Social Adaptation of CAPD and Center Hemodialysis Patients (2008) (0)
- Erythropoiesis Stimulating Agent (ESA) Use for Anemic Cancer and Chronic Kidney Disease (CKD) Patients in 2008: Advocacy for Conservative Use (2008) (0)
- 191:Disease Knowledge and Unmet Patient Education Needs Among Epoetin Recipients on Hemodialysis (HD): Patient Survey Within a Time and Motion Study (2007) (0)
- Coronary surgery and hemodialysis. (1977) (0)
- 40 Time-Dependent Survival Is Not Impacted by Dialyzer Reuse with Peracetic Acid (2011) (0)
- 2nd International Congress of the Vascular Access Society / Author Index for Abstracts (2001) (0)
- The value of PD for the elderly. (1991) (0)
- Front & Back Matter (2015) (0)
- Has CPD been as Effective as Hemodialysis (1989) (0)
- World Kidney Forum Accountable Care Organizations and ESRD: The Time Has Come (2012) (0)
- The RPA. Celebrating 25 years as an advocate for nephrology. (1999) (0)
- Overview of dialysis patient management and future directions (2018) (0)
- 190: Potential for Racial Disparities in the Proposed Medicare Dialysis Prospective Payment System (2010) (0)
- Appropriate application of standardized care to improve ESRD patient outcomes. (2016) (0)
- Elderly patients starting outpatient dialysis not at excessive mortality risk (2014) (0)
- Chapter 21 – Improving Outcomes for End-Stage Renal Disease Patients: Shifting the Quality Paradigm* (2017) (0)
- Difficult Management Problems in Dialysis (1994) (0)
- Case Forum (1998) (0)
- K/doqi Tm Disclaimer K/doqi Advisory Board Members K/doqi Tm Nutrition Work Group Membership Adult Work Group Members Pediatric Work Group Members Nkf-doqi Advisory Council* Nkf-doqi Steering Committee* Acronyms and Abbreviations List Abbreviation Term A1-ag A1-acid Glycoprotein Abw Ef Adjusted Edem (0)
- International variation in influenza vaccination practices and coverage rates among hemodialysis patients : an opportunity to improve care (2012) (0)
- Carbon transcutaneous access device (CTAD). (1979) (0)
- Serum Bicarbonate And Survival In Peritoneal Dialysis (Pd): Comparison With Hemodialysis (Hd) (2012) (0)
- Optimizing outcomes in hemodialysis. (1998) (0)
- For-profit dialysis providers. (2014) (0)
- Ownership of dialysis facilities and patients' survival. (2000) (0)
- A "Quiet Revolution" in Nephrology: Challenges and Opportunities for Advancing the Treatment of Chronic Kidney Disease (2010) (0)
- What common practices in dialysis units can be altered to improve patient care? (2004) (0)
- Comprar Handbook of Dialysis Therapy | Allen R. Nissenson | 9781416041979 | Saunders (2007) (0)
- Acknowledgement of Reviewers (2008) (0)
- PUK24 THE IMPACT OF ADDING A RACIAL CASE MIX ADJUSTER TO MEDICARE DIALYSIS REMIBURSEMENT: CORRECTING A POTENTIAL BIAS (2010) (0)
- Rise in serum enzymes induced by hemodialysis (1983) (0)
- Acute renal insufficiency. (1975) (0)
- Strategies to improve access management. (2016) (0)
- Subject Index, Vol. 10, 1990 (1990) (0)
- 239: Hypertension Management Improved for In-Center Nocturnal Dialysis Patients Compared to Conventional Dialysis Patients (2010) (0)
- CORE CURRICULUM IN NEPHROLOGY Economics of Clinical Nephrology Practice (2004) (0)
- 293: Association of Pre-Transplant Serum Creatinine as a Potential Muscle Mass Surrogate and 5-Year Patient and Graft Survival in 10,090 Hemodialysis Patients (2010) (0)
- Emphasizing patient choice (2003) (0)
- Working Patients and Years on Dialysis: A Review (2015) (0)
- 82: Hemoglobin A1c and 5-Year Survival in 2,798 Chronic Peritoneal Dialysis Patients With Diabetes Mellitus (2010) (0)
- Quiz of the Month. Answers (2004) (0)
- Contents Vol. 40, No. 4, 2015 (2015) (0)
- 156: Paricalcitol Treated Hemodialysis Patients Utilize Less Erythropoietin than Patients Not Receiving Treatment for Secondary Hyperparathyroidism [SHPT] (2010) (0)
- ialysis Outcomes as a easure of Adequacy of Dialysis (2005) (0)
- Charles Leonard von Hess and Hugh McGuigan (2012) (0)
- Re-importation of pharmaceuticals may be unsafe: Lessons learned from the RADAR assessment of erythropoietin (EPO)-associated pure red cell aplasia (PRCA). (2004) (0)
- Dialysis Dietary Potassium Intake and Mortality in Long-term Hemodialysis Patients (2010) (0)
- Leukocyte sequestration during hemodialysis. (1991) (0)
- Dr. Nissenson Replies (1997) (0)
- [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics]. (1974) (0)
- Economics of clinical nephrology practice. (2004) (0)
- Epoetin dosing and dialysis facility ownership. Authors' reply (2007) (0)
- A level playing field for patient access to transplant. (2016) (0)
- Collaboration key in winning NQF endorsement for medication management measure. (2017) (0)
- Renal Replacement Therapy in the Intensive Care Unit (2009) (0)
- CK Isoenzymes in CAPD and Hemodialysis Patients (1986) (0)
- Ethnicity and Chronic Kidney Disease—United States (2020) (0)
- Consultant List (2002) (0)
- Specialist practices as medical homes. (2010) (0)
- Anemia of Chronic Kidney Disease and its Management with Recombinant Human Erythropoietin and Darbepoetin Alfa (2002) (0)
- and Reports (RADAR) Project epoetin: a follow-up report from the Research on Adverse Drug Events antierythropoietin antibodies in patients treated with recombinant Long-term outcome of individuals with pure red cell aplasia and (2013) (0)
- Contents Vol. 35, 2012 (2012) (0)
- Transferrin oversaturation. (1999) (0)
- 39 Dialyzer Reuse with Peracetic Acid Does Not Impact Patient Mortality (2011) (0)
- Gram-negative bacteraemia in haemodialysis (2015) (0)
- Developing a blueprint for quality. (2014) (0)
- Contents Vol. 36, 2013 (2014) (0)
- Erythropoietin, Iron Depletion and Relative Thrombocytosis: A Possible Explanation for Hemoglobin-Survival Paradox in Chronic Kidney Disease (2017) (0)
- Comprar Current Essentials of Diagnosis & Treatment in Nephrology & Hypertension | Allen Nissenson | 9780071447874 | Mcgraw-Hill Education (2009) (0)
- 155: Improved Survival Among Paricalcitol Treated Hemodialysis Patients Compared With No Treatment for Secondary Hyperparathyroidism [SHPT] Is Independent of Baseline iPTH Levels (2010) (0)
- Vascular damage and access in CKD (2012) (0)
- CHAPTER 72 – Impact of Anemia and Its Correction on Brain Function (2008) (0)
- 131: Comparison of Mortality of Incident Peritoneal Dialysis (Pd) and Hemodialysis (Hd) Patients by Age and Diabetes in a National Cohort (2010) (0)
- Nephrology in the future. (1998) (0)
- Original Investigation Effect of Age and Dialysis Vintage on Obesity Paradox in Long-term Hemodialysis Patients (2014) (0)
- The National Anaemia Action Council, Inc.: the primary North American resource for anaemia education and research (2005) (0)
- Comprar Nephrology Secrets, 3rd Edition | Edgar V. Lerma | 9781416033622 | Mosby (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Allen R. Nissenson?
Allen R. Nissenson is affiliated with the following schools:
